News

Eli Lilly’s donanemab slows early stages of Alzheimer’s disease, study shows

Ken Alltucker, USA TODAYComments Off on Eli Lilly’s donanemab slows early stages of Alzheimer’s disease, study shows

The data published Monday in the Journal of the American Medical Association found the drug donanemab slowed decline by 35% compared to placebo.

     
Ken Alltucker, USA TODAY
http://api-internal.usatoday.com.akadns.net

Related Articles
News

2017 in review: The ‘Wonder’-filled highs (and lows) of the year in movies

USA TODAY

USA TODAY looks at the highs (‘Wonder Woman’) and lows (‘Valerian and the City of a Thousand Planets’) of the year’s movies.
News

Shooter among dead in New Mexico high school shooting

The (Farmington, N.M.) Daily Times

Two students were killed when a shooter opened fire at Aztec High School.
News

Nativity scene and Christmas tree unveiled at the Vatican

Newslook

Nativity scene and Christmas tree unveiled at the Vatican Video provided by AFP